Aggregated IgG inhibits the differentiation of human fibrocytes

Journal of Leukocyte Biology

Volumn 79, Issue 6, 2006, Pages 1242-1251

  Pilling, Darrell ^a   Tucker, Nancy M ^a   Gomer, Richard H ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

Cellular differentiation; Fc R; Inflammation; Monocytes; Serum amyloid P

Indexed keywords

3 (1 METHYL 1H INDOL 3 YL METHYLENE) 2 OXO 2,3 DIHYDRO 1H INDOLE 5 SULFONAMIDE; FC GAMMA RECEPTOR I; FC GAMMA RECEPTOR II; FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD32; MONOCLONAL ANTIBODY CD64; PROTEIN KINASE INHIBITOR; PROTEIN KINASE SYK; SERUM AMYLOID P; SULFONAMIDE; BIOPOLYMER; IMMUNOGLOBULIN A POLYMER; IMMUNOGLOBULIN FC FRAGMENT; POLYMERIC IGG; POLYMERIC IGM; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; IMMUNOLOGY; MONOCYTE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

ANTIBODIES, MONOCLONAL; BIOPOLYMERS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOCYTES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG; SERUM AMYLOID P-COMPONENT; SRC-FAMILY KINASES;

EID: 33746920906     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0805456     Document Type: Article

References (86)

1. Martin, P. (1997) Wound healing - aiming for perfect skin regeneration. Science 276, 75-81.
2. Gordon, S. (1999) Development and distribution of mononuclear phagocytes: relevance to inflammation. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, R. Synderman, eds.), Philadelphia, PA, Lippincott, Williams and Wilkins, 35-48..
3. Orteu, C. H., Poulter, L. W., Rustin, M. H. A., Sabin, C. A., Salmon, M., Akbar, A. N. (1998) The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J. Immunol. 161, 1619-1629.
4. Greenhalgh, D. G. (1998) The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30, 1019-1030.
5. Clark, R. A. (2001) Fibrin and wound healing Ann. N. Y. Acad. Sci. 936, 355-367.
6. Abe, R., Donnelly, S. C., Peng, T., Bucala, R., Metz, C. N. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562.
7. Majno, G. (1998) Chronic inflammation: links with angiogenesis and wound healing. Am. J. Pathol. 153, 1035-1039.
8. Metz, C. N. (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell. Mol. Life Sci. 60, 1342-1350.
9. Mori, L., Bellini, A., Stacey, M. A., Schmidt, M., Mattoli, S. (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp. Cell Res. 304, 81-90.
10. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., Cerami, A. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
11. Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M., Bucala, R. (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160, 419-425.
12. Hartlapp, I., Abe, R., Saeed, R. W., Peng, T., Voelter, W., Bucala, R., Metz, C. N. (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 15, 2215-2224.
13. Chesney, J., Bacher, M., Bender, A., Bucala, R. (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl. Acad. Sci. USA 94, 6307-6312.
14. Cowper, S. E. (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr. Opin. Rheumatol. 15, 785-790.
15. Chesney, J., Bucala, R. (2000) Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis. Curr. Rheumatol. Rep. 2, 501-505.
16. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., Strieter, R. M. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
17. Schmidt, M., Sun, G., Stacey, M. A., Mori, L., Mattoli, S. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389.
18. Pilling, D., Buckley, C. D., Salmon, M., Gomer, R. H. (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 171, 5537-5546.
19. Yang, L., Scott, P. G., Giuffre, J., Shankowsky, H. A., Ghahary, A., Tredget, E. E. (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab. Invest. 82, 1183-1192.
20. Steel, D. M., Whitehead, A. S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81-88.
21. Gewurz, H., Zhang, X. H., Lint, T. F. (1995) Structure and function of the pentraxins. Curr. Opin. Immunol. 7, 54-64.
22. Hutchinson, W. L., Hohenester, E., Pepys, M. B. (2000) Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol. Med. 6, 482-493.
23. Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, P. M., Hohenester, E. (1997) Amyloid P component. A critical review. Amyloid 4, 274-295.
24. Noursadeghi, M., Bickerstaff, M. C., Gallimore, J. R., Herbert, J., Cohen, J., Pepys, M. B. (2000) Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. USA 97, 14584-14589.
25. Bickerstaff, M. C., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J., Walport, M. J., Pepys, M. B. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5, 694-697.
26. Bijl, M., Horst, G., Bijzet, J., Bootsma, H., Limburg, P. C., Kallenberg, C. G. (2003) Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum. 48, 248-254.
27. Du Clos, T. W. (1989) C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143, 2553-2559.
28. Ravetch, J. V., Kinet, J. P. (1991) Fc receptors. Annu. Rev. Immunol. 9, 457-492.
29. Hulett, M. D., Hogarth, P. M. (1994) Molecular basis of Fc receptor function. Adv. Immunol. 57, 1-127.
30. Daeron, M. (1997) Structural bases of Fc γ R functions. Int. Rev. Immunol. 16, 1-27.
31. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
32. Ziegler-Heitbrock, H. W. L. (1996) Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol. Today 17, 424-428.
33. Nimmerjahn, F., Bruhns, P., Horiuchi, K., Ravetch, J. V. (2005) FcγRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23, 41-51.
34. Davis, R. S., Dennis Jr., G., Odom, M. R., Gibson, A. W., Kimberly, R. P., Burrows, P. D., Cooper, M. D. (2002) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol. Rev. 190, 123-136.
35. Bharadwaj, D., Mold, C., Markham, E., Du Clos, T. W. (2001) Serum amyloid P component binds to Fc γ receptors and opsonizes particles for phagocytosis. J. Immunol. 166, 6735-6741.
36. Mold, C., Gresham, H. D., Du Clos, T. W. (2001) Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc γ Rs. J. Immunol. 166, 1200-1205.
37. Marnell, L. L., Mold, C., Volzer, M. A., Burlingame, R. W., Du Clos, T. W. (1995) C-reactive protein binds to Fc γ RI in transfected COS cells. J. Immunol. 155, 2185-2193.
38. Bharadwaj, D., Stein, M. P., Volzer, M., Mold, C., Du Clos, T. W. (1999) The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J. Exp. Med. 190, 585-590.
39. Du Clos, T. W., Mold, C., Edberg, J. C., Kimberly, R. P. (2001) Response: human C-reactive protein does not bind to FcγRIIa on phagocytic cells. J. Clin. Invest. 107, 642.
40. Bodman-Smith, K. B., Gregory, R. E., Harrison, P. T., Raynes, J. G. (2004) FcγRIIa expression with FcγRI results in C-reactive protein- and IgG-mediated phagocytosis. J. Leukoc. Biol. 75, 1029-1035.
41. Bodman-Smith, K. B., Melendez, A. J., Campbell, I., Harrison, P. T., Allen, J. M., Raynes, J. G. (2002) C-reactive protein-mediated phagocytosis and phospholipase D signaling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunology 107, 252-260.
42. Chi, M., Tridandapani, S., Zhong, W., Coggeshall, K. M., Mortensen, R. F. (2002) C-reactive protein induces signaling through Fc γ RIIa on HL-60 granulocytes. J. Immunol. 168, 1413-1418.
43. Daeron, M. (1997) Fc receptor biology. Annu. Rev. Immunol. 15, 203-234.
44. Ravetch, J. V., Bolland, S. (2001) IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290.
45. Dougherty, G. J., Selvendran, Y., Murdoch, S., Palmer, D. G., Hogg, N. (1987) The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur. J. Immunol. 17, 1453-1459.
46. Schlossman, S. F., Boumsell, L., Gilks, W., Harlan, J. M., Kishimoto, T., Ritz, J., Shaw, S., Silverstein, R. L., Springer, T. A., Tedder, T. F., Todd, R. F. (1995) Leukocyte Typing V: White Cell Differentiation Antigens, United Kingdom, Oxford University Press.
47. Harrison, P. T., Allen, J. M. (1998) High affinity IgG binding by FcγRI (CD64) is modulated by two distinct IgSF domains and the transmembrane domain of the receptor. Protein Eng. 11, 225-232.
48. Pfefferkorn, L. C., van de Winkel, J. G., Swink, S. L. (1995) A novel role for IgG-Fc. Transductional potentiation for human high-affinity Fc γ receptor (Fc γ RI) signaling. J. Biol. Chem. 270, 8164-8171.
49. Monteiro, R. C., van de Winkel, J. G. J. (2003) IgA Fc receptors. Annu. Rev. Immunol. 21, 177-204.
50. Gould, H. J., Sutton, B. J., Beavil, A. J., Beavil, R. L., McCloskey, N., Coker, H. A., Fear, D., Smurthwaite, L. (2003) The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21, 579-628.
51. Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J., Sutherland, G. R., Endo, Y., Fujita, T., Miyabayashi, T., Sakano, S., Tsuji, T., Nakayama, E., Phillips, J. H., Lanier, L. L., Nakauchi, H. (2000) Fc α/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1, 441-446.
52. Brown, M. R., Anderson, B. E. (1993) Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes. J. Immunol. 151, 2087-2095.
53. Duchemin, A. M., Anderson, C. L. (1997) Association of non-receptor protein tyrosine kinases with the Fc γ RI/γ-chain complex in monocytic cells. J. Immunol. 158, 865-871.
54. Ghazizadeh, S., Bolen, J. B., Fleit, H. B. (1994) Physical and functional association of Src-related protein tyrosine kinases with Fc γ RII in monocytic THP-1 cells. J. Biol. Chem. 269, 8878-8884.
55. Huang, Z. Y., Hunter, S., Kim, M. K., Chien, P., Worth, R. G., Indik, Z. K., Schreiber, A. D. (2004) The monocyte Fcγ receptors FcgγRI/γ and FcγRIIA differ in their interaction with Syk and with Src-related tyrosine kinases. J. Leukoc. Biol. 76, 491-499.
56. Korade-Mirnics, Z., Corey, S. J. (2000) Src kinase-mediated signaling in leukocytes. J. Leukoc. Biol. 68, 603-613.
57. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P., Tybulewicz, V. L. (2000) Tyrosine kinase SYK: essential functions for immunoreceptor signaling. Immunol. Today 21, 148-154.
58. Bain, J., McLauchlan, H., Elliott, M., Cohen, P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204.
59. Lai, J. Y. Q., Cox, P. J., Patel, R., Sadiq, S., Aldous, D. J., Thurairatnam, S., Smith, K., Wheeler, D., Jagpal, S., Parveen, S. (2003) Potent small molecule inhibitors of spleen tyrosine kinase (Syk). Bioorg. Med. Chem. Lett. 13, 3111-3114.
60. Sada, K., Takano, T., Yanagi, S., Yamamura, H. (2001) Structure and function of Syk protein-tyrosine kinase. J. Biochem. (Tokyo) 130, 177-186.
61. Ashikawa, K., Majumdar, S., Banerjee, S., Bharti, A. C., Shishodia, S., Aggarwal, B. B. (2002) Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκB/α kinase and p65 phosphorylation. J. Immunol. 169, 6490-6497.
62. Su, L., David, M. (2000) Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. J. Biol. Chem. 275, 12661-12666.
63. Zheng, J., Ramirez, V. D. (1999) Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem. Biophys. Res. Commun. 261, 499-503.
64. Akbar, A. N., Salmon, M., Ivory, K., Taki, S., Pilling, D., Janossy, G. (1991) Human CD4+ CD45RO+ and CD4+ CD45RA+ T cells synergize in response to alloantigens. Eur. J. Immunol. 21, 2517-2522.
65. Salmon, M., Pilling, D., Borthwick, N. J., Viner, N., Janossy, G., Bacon, P. A., Akbar, A. N. (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24, 892-899.
66. Pilling, D., Akbar, A. N., Bacon, P. A., Salmon, M. (1996) CD4+ CD45RA+ T cells from adults respond to recall antigens after CD28 ligation. Int. Immunol. 8, 1737-1742.
67. Kim, M. K., Pan, X. Q., Huang, Z. Y., Hunter, S., Hwang, P. H., Indik, Z. K., Schreiber, A. D. (2001) Fc γ receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis. Clin. Immunol. 98, 125-132.
68. Hunter, S., Sato, N., Kim, M. K., Huang, Z. Y., Chu, D. H., Park, J. G., Schreiber, A. D. (1999) Structural requirements of Syk kinase for Fcγ receptor-mediated phagocytosis. Exp. Hematol. 27, 875-884.
69. Saeland, E., van Royen, A., Hendriksen, K., Vile-Weekhout, H., Rijkers, G. T., Sanders, L. A. M., van de Winkel, J. G. J. (2001) Human C-reactive protein does not bind to FcγRIIa on phagocytic cells. J. Clin. Invest. 107, 641-642.
70. Manolov, D. E., Rocker, C., Hombach, V., Nienhaus, G. U., Torzewski, J. (2004) Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa. Arterioscler. Thromb. Vasc. Biol. 24, 2372-2377.
71. Cochrane, C. G., Weigle, W. O., Dixon, F. J. (1959) The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J. Exp. Med. 110, 481-494.
72. Waller, M. (1974) IgG hydrolysis in abscesses. I. A study of the IgG in human abscess fluid. Immunology 26, 725-733.
73. Haslett, C., Henson, P. M. (1988) Resolution of inflammation. In The Molecular and Cellular Biology of Wound Repair (R. A. F. Clark, P. M. Henson, eds.), New York, NY, Plenum, 185-211.
74. Shearer, J. D., Coulter, C. F., Engeland, W. C., Roth, R. A., Caldwell, M. D. (1997) Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56). Am. J. Physiol. 273, E657-E664.
75. Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D., Salmon, M. (2001) Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22, 199-204.
76. Feldmann, M., Brennan, F. M., Maini, R. N. (1996) Rheumatoid arthritis. Cell 85, 307-310.
77. Firestein, G. S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
78. Cooke, T. D., Hurd, E. R., Jasin, H. E., Bienenstock, J., Ziff, M. (1975) Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum. 18, 541-551.
79. Shiozawa, S., Jasin, H. E., Ziff, M. (1980) Absence of immunoglobulins in rheumatoid cartilage-pannus junctions. Arthritis Rheum. 23, 816-821.
80. Grab, D. J., Lanners, H. N., Williams, W. L., Bucala, R. (1999) Peripheral blood fibrocytes with foamy virus infection-like morphology. Hum. Pathol. 30, 1395-1396.
81. Yang, L., Scott, P. G., Dodd, C., Medina, A., Jiao, H., Shankowsky, H. A., Ghahary, A., Tredget, E. E. (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen. 13, 398-404.
82. Singer, A. J., Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746.
83. Pilling, D., Akbar, A. N., Girdlestone, J., Orteu, C. H., Borthwick, N. J., Amft, N., Scheel-Toellner, D., Buckley, C. D., Salmon, M. (1999) Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29, 1041-1050.
84. Scheel-Toellner, D., Pilling, D., Akbar, A. N., Hardie, D., Lombardi, G., Salmon, M., Lord, J. M. (1999) Inhibition of T cell apoptosis by IFN-β rapidly reverses nuclear translocation of protein kinase C-δ. Eur. J. Immunol. 29, 2603-2612.
85. Buckley, C. D., Amft, N., Bradfield, P. F., Pilling, D., Ross, E., Arenzana-Seisdedos, F., Amara, A., Curnow, S. J., Lord, J. M., Scheel-Toellner, D., Salmon, M. (2000) Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 165, 3423-3429.
86. Buckley, C. D. (2003) Why do leucocytes accumulate within chronically inflamed joints? Rheumatology (Oxford) 42, 1433-1444.